# A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

> **NCT01372150** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 340 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** desvenlafaxine succinate sustained release
- **DRUG:** fluoxetine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01372150
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11-17
- **Primary completion:** 2015-03-20
- **Final completion:** 2015-03-20
- **Target enrollment:** 340 (ACTUAL)
- **Last updated:** 2019-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01372150

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01372150, "A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD". Retrieved via MORVS 2026-10-17 from https://api.morvs.ai/clinical/NCT01372150. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*